James Mulé

Title: James Mulé: Innovator in Bioengineering Tertiary Lymphoid Structures

Introduction

James Mulé is a prominent inventor based in Odessa, Florida, known for his significant contributions to the field of bioengineering. His innovative work focuses on the development of tertiary lymphoid structures (TLSs) using advanced materials, which has implications for cancer research and treatment.

Latest Patents

James Mulé holds a patent for "Bioengineering tertiary lymphoid structures using chitosan-based hydrogels." This patent outlines a method for bioengineering TLSs in animals, such as mice, by utilizing chemokine-releasing microparticles or cells that can be implanted. The compositions involve chitosan hydrogels that incorporate these microparticles or cells, highlighting the importance of stromal cells in the recruitment and organization of lymphocytes within TLSs.

Career Highlights

James Mulé is affiliated with the H. Lee Moffitt Cancer Center and Research Institute, Inc., where he conducts research aimed at advancing cancer therapies. His work is pivotal in understanding how to manipulate the immune system to improve patient outcomes.

Collaborations

James collaborates with esteemed colleagues, including Rana Falahat and Genyuan Zhu, to further enhance the research and development of bioengineering techniques in cancer treatment.

Conclusion

James Mulé's innovative contributions to bioengineering and cancer research exemplify the impact of scientific advancements on healthcare. His work continues to pave the way for new therapeutic strategies in the fight against cancer.